Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacists granted power to limit supply of 3 ‘high demand’ HRT products

Pharmacists will be able to limit the supply of HRT products Oestrogel, Ovestin cream and Premique Low Dose to three months, regardless of the prescription, without needing to seek authorisation from the prescriber.

Health secretary Sajid Javid has today (April 29) issued serious shortage protocols (SSPs) for the three “high demand” hormone replacement therapy (HRT) products “to ensure women are able to access the HRT they need”.

The SSPs – which are due to expire on July 29 – allow community pharmacists to supply the three specified HRT products according to the protocol rather than the written prescription, without needing to seek authorisation from the prescriber, the Department of Health and Social Care (DH) explained.

“This will even out distribution of in-demand for products such as Oestrogels that have recently experienced issues due to rising demand. Pharmacists are expected to use their professional judgement when deciding to apply the SSP and patients must be consulted,” it added.

“Women who have a prescription for more than three months but are only able to access three months’ supply will not have to pay an additional prescription charge,” the DH said.

Pharmacy minister and minister for womens' health Maria Caulfield said the government would do "everything in our power" to ensure women can access their HRT medicines.

Meanwhile, head of the government's HRT taskforce Madeline McTernan said the move signaled a "move in the right direction" in tackling HRT supply issues "and ensuring ongoing, reliable accessibility".

 

Related Content

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD136088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel